American Journal of Epidemiology Advance Access published online on August 19, 2008
American Journal of Epidemiology, doi:10.1093/aje/kwn226
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Letter to the Editor |
THE AUTHORS REPLY
1 Department of Epidemiological Research, Statens Serum Institut, 2300 Copenhagen S, Denmark
2 Department of Bacteriology, Mycology and Parasitology, Statens Serum Institut, 2300 Copenhagen S, Denmark
3 Viral Epidemiology Branch, National Cancer Institute, Bethesda, MD 20892
(e-mail: tta{at}ssi.dk)
We thank Dr. Davis (1) for his interest in our study (2). Dr. Davis questions our interpretation of the results and states that genetics may well be critical, but only given exposure.
We previously reported that exposure to Streptococcus pneumoniae appears to be almost ubiquitous in Denmark (3). Most children appear to become infected in the first year of life, and those who escape infection will most likely acquire it soon thereafter (e.g., at a day-care center). Since everyone in Denmark is exposed early in life, one would suppose that invasive pneumococcal disease (IPD) would cluster within families if genetics were of great importance.
As we stressed in our article (2), analysis of national population-based data is not appropriate to determine whether genetic factors can be important within particular families. Elsewhere, we and others have reported strong associations between IPD and specific genetic conditions that result in structural or immunologic abnormalities (4–8). However, we feel confident that these genetic predispositions are too infrequent to play a major role in determining the risk of IPD at the population level. Thus, IPD risk in populations appears to be dominated by environmental exposures. For example, concurrent infections with other respiratory agents may establish a milieu in which S. pneumoniae infection can become established as an invasive condition (9).
ACKNOWLEDGMENTS
Conflict of interest: none declared.
References
- Davis R. Re: "Genetic susceptibility to severe infection in families with invasive pneumococcal disease." (Letter). Am J Epidemiol. (2008) 000((00)):000–000.
- Hjuler T, Poulsen G, Wohlfahrt J, et al. Genetic susceptibility to severe infection in families with invasive pneumococcal disease. Am J Epidemiol. (2008) 167((7)):814–819.
[Abstract/Free Full Text] - Hjuler T, Wohlfahrt J, Simonsen J, et al. Perinatal and crowding-related risk factors for invasive pneumococcal disease in infants and young children: a population-based case control study. Clin Infect Dis. (2007) 44((8)):1051–1056.[CrossRef][Web of Science][Medline]
- Hjuler T, Wohlfahrt J, Staum Kaltoft M, et al. Risks of invasive pneumococcal disease in children with underlying chronic diseases. Pediatrics (2008) 122((1)):e26–e32.
[Abstract/Free Full Text] - Tamouza R, Neonato MG, Busson M, et al. Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol. (2002) 63((3)):194–199.[CrossRef][Web of Science][Medline]
- Kronborg G, Weis N, Madsen HO, et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis. (2002) 185((10)):1517–1520.[CrossRef][Web of Science][Medline]
- Roy S, Knox K, Segal S, et al. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet (2002) 359((9317)):1569–1573.[CrossRef][Web of Science][Medline]
- Yee AM, Phan HM, Zuniga R, et al. Association between Fc
RIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis. (2000) 30((1)):25–28.[CrossRef][Web of Science][Medline] - Stensballe L, Hjuler T, Andersen A, et al. Hospitalization for respiratory syncytial virus infection and invasive pneumococcal disease in Danish children aged <2 years: a population-based cohort study. Clin Infect Dis. (2008) 46((8)):1165–1171.[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||